A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea.

Conditions:   Ulcerative Colitis;   Crohn's Disease;   Inflammatory Bowel Disease (IBD) Intervention:   Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials